Tag: GW Pharmaceuticals

Medical Marijuana Medicine Epidiolex: 54% Decrease In Seizures Reported By American Academy of Neurology

Medical Marijuana Medicine Epidiolex: 54% Decrease In Seizures Reported By American Academy of Neurology

American Academy of Neurology has released some new data on GW Pharmaceuticals’ medical marijuana “investigational medicine Epidiolex® (pure cannabidiol, or CBD)”. The study, the results of which “will be presented at the American Academy of Neurology’s 67th Annual Meeting in Washington, DC, April 18 to 25, 2015″, involved 213 people (toddlers […]